SEC Form 4 · accession 0001587221-17-000018
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Georgia Erbez
Officer — CFO and Chief Business Officer
Period of report
May 25, 2017
Accepted (ET)
May 25, 2017 · 8:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2017 | P | 68,000 | $1.32 | A | 115,750 | D |
Table II — derivative securities
No Table II lines on this filing.